Levi & Korsinsky, LLP announces that a ATHA class action lawsuit has been filed on behalf of investors who purchased Athira Pharma, Inc. (ATHA) securities between September 18, 2020 and June 17, 2021 For more on the ATHA Lawsuit please contact us today.

According to the Athira Pharma lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the research conducted by Defendant Kawas, which formed the foundation for Athira’s product candidates and intellectual property, was tainted by Kawas’ scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.

TO LEARN MORE ABOUT THE ATHA CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Athira Pharma you have until August 24, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com